These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33641134)

  • 21. Talk of the town in 2021: Covid-19 vaccines likely take centre stage.
    Höglund P
    Scand J Immunol; 2021 Jan; 93(1):e13014. PubMed ID: 33372339
    [No Abstract]   [Full Text] [Related]  

  • 22. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.
    Kesselheim AS; Darrow JJ; Kulldorff M; Brown BL; Mitra-Majumdar M; Lee CC; Moneer O; Avorn J
    Health Aff (Millwood); 2021 Jan; 40(1):25-32. PubMed ID: 33211535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Messengers of hope.
    Nat Biotechnol; 2021 Jan; 39(1):1. PubMed ID: 33376248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 vaccines: building and maintaining confidence.
    The Lancet Haematology
    Lancet Haematol; 2021 May; 8(5):e305. PubMed ID: 33894163
    [No Abstract]   [Full Text] [Related]  

  • 25. Answering Key Questions About COVID-19 Vaccines.
    Goodman JL; Grabenstein JD; Braun MM
    JAMA; 2020 Nov; 324(20):2027-2028. PubMed ID: 33064145
    [No Abstract]   [Full Text] [Related]  

  • 26. What it will take to equitably distribute a COVID-19 vaccine.
    Medina-Walpole A
    Geriatr Nurs; 2020; 41(6):1028-1029. PubMed ID: 33187757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    Sharfstein JM; Goodman JL; Borio L
    JAMA; 2021 Mar; 325(12):1153-1154. PubMed ID: 33587124
    [No Abstract]   [Full Text] [Related]  

  • 28. Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA.
    Pai SM; Othman AA; Rusch L; Masters JC; Greene D; Rogge M; Gries JM; Clementi W; Kumar P; Younis I; Salem AH; Gaynes BI; Pastino G; Derendorf H;
    J Clin Pharmacol; 2021 Mar; 61(3):277-279. PubMed ID: 33274473
    [No Abstract]   [Full Text] [Related]  

  • 29. Reporting of AstraZeneca studies may have caused vaccine reservations.
    Bignardi G
    BMJ; 2021 Apr; 373():n937. PubMed ID: 33846122
    [No Abstract]   [Full Text] [Related]  

  • 30. The online anti-vaccine movement in the age of COVID-19.
    Burki T
    Lancet Digit Health; 2020 Oct; 2(10):e504-e505. PubMed ID: 32984795
    [No Abstract]   [Full Text] [Related]  

  • 31. A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
    Meissner HC
    JAMA; 2021 Feb; 325(8):721-722. PubMed ID: 33544127
    [No Abstract]   [Full Text] [Related]  

  • 32. Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    Lee GM; Romero JR; Bell BP
    JAMA; 2020 Nov; 324(19):1937-1938. PubMed ID: 33064152
    [No Abstract]   [Full Text] [Related]  

  • 33. The UK has approved a COVID vaccine - here's what scientists now want to know.
    Ledford H; Cyranoski D; Van Noorden R
    Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-Coronavirus Disease 2019 Vaccines: Need for Informed Consent.
    Mazraani M; Barbari A
    Exp Clin Transplant; 2021 Aug; 19(8):753-762. PubMed ID: 34407747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tackling sheepishness about a COVID-19 vaccine for the sake of herd immunity.
    Gildea F
    Perspect Public Health; 2020 Nov; 140(6):301-302. PubMed ID: 33222626
    [No Abstract]   [Full Text] [Related]  

  • 36. Arrival of Covid-19 vaccine cheers Alaska hospital's staff.
    Traynor K
    Am J Health Syst Pharm; 2021 Feb; 78(5):367-368. PubMed ID: 33605990
    [No Abstract]   [Full Text] [Related]  

  • 37. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
    Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1922-1924. PubMed ID: 33332292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on the global vaccine development for coronavirus.
    Rab S; Afjal ; Javaid M; Haleem A; Vaishya R
    Diabetes Metab Syndr; 2020; 14(6):2053-2055. PubMed ID: 33113472
    [No Abstract]   [Full Text] [Related]  

  • 39. Nanomedicine and the COVID-19 vaccines.
    Nat Nanotechnol; 2020 Dec; 15(12):963. PubMed ID: 33247210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.